- Home
- BATL vs IRIX Comparison
BATL vs IRIX Comparison
Compare BATL & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BATL
- IRIX
- Stock Information
- Founded
- BATL 1987
- IRIX 1989
- Country
- BATL United States
- IRIX United States
- Employees
- BATL N/A
- IRIX N/A
- Industry
- BATL Oil & Gas Production
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BATL Energy
- IRIX Health Care
- Exchange
- BATL Nasdaq
- IRIX Nasdaq
- Market Cap
- BATL 20.6M
- IRIX 16.5M
- IPO Year
- BATL N/A
- IRIX 1996
- Fundamental
- Price
- BATL $1.35
- IRIX $1.41
- Analyst Decision
- BATL
- IRIX
- Analyst Count
- BATL 0
- IRIX 0
- Target Price
- BATL N/A
- IRIX N/A
- AVG Volume (30 Days)
- BATL 113.7K
- IRIX 156.5K
- Earning Date
- BATL 08-13-2025
- IRIX 08-07-2025
- Dividend Yield
- BATL N/A
- IRIX N/A
- EPS Growth
- BATL N/A
- IRIX N/A
- EPS
- BATL N/A
- IRIX N/A
- Revenue
- BATL $191,498,000.00
- IRIX $48,804,000.00
- Revenue This Year
- BATL N/A
- IRIX $9.61
- Revenue Next Year
- BATL N/A
- IRIX N/A
- P/E Ratio
- BATL N/A
- IRIX N/A
- Revenue Growth
- BATL N/A
- IRIX N/A
- 52 Week Low
- BATL $1.05
- IRIX $0.78
- 52 Week High
- BATL $6.89
- IRIX $2.14
- Technical
- Relative Strength Index (RSI)
- BATL 45.53
- IRIX 73.03
- Support Level
- BATL $1.31
- IRIX $1.31
- Resistance Level
- BATL $1.40
- IRIX $1.45
- Average True Range (ATR)
- BATL 0.09
- IRIX 0.12
- MACD
- BATL 0.00
- IRIX 0.04
- Stochastic Oscillator
- BATL 63.64
- IRIX 71.87
About BATL Battalion Oil Corporation
Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.